Phase III randomized, placebo (PL)-controlled, double-blind study of intravenous calcium/magnesium (CaMg) to prevent oxaliplatin-induced sensory neurotoxicity (sNT), N08CB: An alliance for clinical trials in oncology study.
Charles L. Loprinzi
No relevant relationships to disclose
Rui Qin
No relevant relationships to disclose
Shaker R. Dakhil
No relevant relationships to disclose
Louis Fehrenbacher
No relevant relationships to disclose
Philip J. Stella
No relevant relationships to disclose
Pamela J. Atherton
No relevant relationships to disclose
Drew K. Seisler
No relevant relationships to disclose
Rubina Qamar
No relevant relationships to disclose
Grant Carlton Lewis
No relevant relationships to disclose
Axel Grothey
No relevant relationships to disclose